Jazz Pharmaceuticals plc (JAZZ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Core Insights - The presentation is part of the 44th Annual Healthcare Conference, featuring Jazz's CEO Renée Galá, who emphasizes the company's commitment to advancing its mission and legacy [1][2]. Company Overview - Renée Galá expresses honor in her new role as CEO and aims to build upon the legacy of her predecessor, Bruce Cozadd [2]. - The company is focused on delivering life-changing medicines to patients, enhancing employee experience, and creating shareholder value [2]. Future Strategy - The CEO plans to recap the company's accomplishments for 2025 and discuss future competitive strategies [3].